Related Experiment Video

Updated: Aug 19, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies

R B Bankert1, N K Egilmez, S D Hess

  • 1Dept of Immunology, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, NY 14263, USA. richard.bankert@roswellpark.org

Trends in Immunology
|June 29, 2001
PubMed

Insights

Human-mouse chimeric models using severe combined immunodeficient (SCID) mice show promise for anti-cancer therapy evaluation. This review discusses the strengths and limitations of five common SCID models to improve their reliability.

Area of Science:

  • Oncology
  • Immunology
  • Preclinical Research

Background:

  • Severe combined immunodeficient (SCID) mice are utilized to create human-mouse chimeric models for anti-cancer therapy research.
  • These models involve engrafting human tumors and immunocompetent cells into SCID mice.
  • The reliability of these models is currently debated due to a lack of standardization and potential pitfalls.

Purpose of the Study:

  • To provide an objective discussion on the strengths and limitations of five frequently used SCID mouse models.
  • To summarize the specific applications of these SCID mouse models.
  • To offer suggestions for overcoming variability and improving future model design and use.

Main Methods:

  • Review and summarization of five commonly employed SCID mouse models.
  • Analysis of the specific applications, strengths, and limitations of each model.
  • Identification of strategies to enhance model standardization and reliability.

Main Results:

  • Detailed overview of five distinct SCID mouse models used in cancer research.
  • Discussion of the advantages and disadvantages inherent in each model.
  • Identification of key factors contributing to model variability.

Conclusions:

  • Standardization is crucial for enhancing the reliability of human-mouse chimeric SCID models.
  • Careful selection and design of SCID models are essential for accurate anti-cancer therapy evaluation.
  • Further research and improved methodologies can optimize the use of these valuable preclinical models.

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...